Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 8:42 PM UTC
| NCT Number | NCT06767514 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 780 participants |
| Active Locations | 97 sites in the US |
| Sponsor | Summit Therapeutics |
| Last Updated on CT.gov | September 18, 2026 (4 weeks ago) |
As of October 16, 2026: Clinical trial NCT06767514 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 97 locations across the United States. The study is sponsored by Summit Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06767514 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 97 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06767514 was last updated 4 weeks ago (September 18, 2026). HelloStudys verifies this status automatically.